002932 *ST明德生物
按盤價 
16.740 -0.210 (-1.239%)
16.740 -0.210 (-1.239%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 265,079 | -24.28% | 749,537 | 10,530,278 | 2,829,830 | 959,099 | |
| 減：營業總成本 | 398,464 | -7.87% | 720,146 | 4,497,134 | 1,120,303 | 405,651 | |
| 其中:營業成本 | 169,214 | 4.83% | 342,703 | 3,491,170 | 707,026 | 208,995 | |
| 財務費用 | (1,058) | -88.93% | 5,194 | (34,938) | (5,880) | (2,611) | |
| 資產減值損失 | (13,323) | -84.67% | 4,753 | (646,672) | 0 | -- | |
| 公允價值變動收益 | (863) | -149.72% | 4,589 | 2,760 | 0 | -- | |
| 投資收益 | 104,828 | -21.60% | 120,550 | 35,120 | 673 | 1,310 | |
| 其中：對聯營企業和合營企業的投資收益 | 3,436 | -374.59% | (6,735) | -- | (5,776) | (6,497) | |
| 營業利潤 | (78,386) | -290.32% | 145,194 | 5,079,833 | 1,697,814 | 562,279 | |
| 利潤總額 | (63,794) | -296.80% | 139,889 | 5,076,397 | 1,694,557 | 556,701 | |
| 減：所得稅費用 | 11,268 | 92.57% | 70,673 | 695,843 | 247,869 | 81,073 | |
| 淨利潤 | (75,062) | -382.56% | 69,216 | 4,380,554 | 1,446,688 | 475,628 | |
| 減：非控股權益 | (58,601) | 22.20% | (5,710) | 172,057 | 33,463 | 6,700 | |
| 股東淨利潤 | (16,461) | -122.09% | 74,926 | 4,208,497 | 1,413,224 | 468,928 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.070 | -121.21% | 0.330 | 18.460 | 9.950 | 4.990 | |
| 每股派息 (元) * | -- | -- | 0.120 | 5.200 | 4.500 | 2.000 | |
| 每股淨資產 (元) * | -- | -- | 25.915 | 41.615 | 26.591 | 15.967 | |
| 審計意見 # | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | -- | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 24/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
